Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard A. Miller Insider Profile
11 Followers
Richard A. Miller, Pres, CEO & Director, Director at Pharmacyclics, holds 626.93K shares in Pharmacyclics (Ticker: PCYC), holds 1.77M shares in Corvus Pharmaceuticals (Ticker: CRVS), holds ― shares in Bolt Biotherapeutics (Ticker: BOLT). Most recently, Richard A. Miller ― shares of Pharmacyclics on ― for an estimated value of ―.
Richard A. Miller Pharmacyclics (PCYC)Pres, CEO & Director, Director
Pharmacyclics (PCYC)
Pres, CEO & Director, Director
Ranked #1,534 out of 99,218 Corporate Insiders
Profitable Transactions
10 out of 21 Profitable Transactions
Average Return
+38.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard A. Miller holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard A. Miller
Richard A. Miller's Trading History
Pharmacyclics
―
―
―
―
Corvus Pharmaceuticals
May 14, 2024
President & CEO, Director
Uninformative Sell
―
$16.69M
Bolt Biotherapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Richard A. Miller's performance on stock
You May Also Like
Richard A. Miller insider profile FAQ
What is the percentage of profitable transactions made by Richard A. Miller?
The percentage of profitable transactions made by Richard A. Miller is 48%.
What is the average return per transaction made by Richard A. Miller?
The average return per transaction made by Richard A. Miller is 38.00%.
What stocks does Richard A. Miller hold?
Richard A. Miller holds: PCYC, CRVS, BOLT stocks.
What was Richard A. Miller’s latest transaction?
Richard A. Miller latest transaction was an Uninformative Buy of ―.
What was Richard A. Miller's most profitable transaction?
Richard A. Miller’s most profitable transaction was an Informative Buy of CRVS stock on May 7, 2024. The return on the trade was 441.60%.
What is Richard A. Miller's role in Pharmacyclics?
Richard A. Miller's role in Pharmacyclics is Pres, CEO & Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.